Existing protocols for β-cell differentiation are ine cient and result in a mixed population of cells consisting of pancreatic progenitors and immature β-like cells that have limited glucose stimulated insulin secretion.Here, we describe a protocol to rapidly and e ciently generate functional and mature pancreatic islet β-cells from human pluripotent stem cells \(hPSCs) by recapitulating many aspects of pancreatic development in vitro.We rst generate ~50% C-peptide+NKX6.1+insulin producing cells in 20 days by differentiating hPSCs through the stages of endoderm, pancreatic progenitors and endocrine progenitors.These β-like cells are then isolated and re-aggregated to form islet sized enriched betaclusters \(eBCs), mimicking the process of endocrine cell clustering that occurs during islet organogenesis.eBCs share physiological properties of human islets, including dynamic insulin secretion, calcium signaling, sulfonylurea response, and mitochondrial energization.The results of this protocol is detailed in the publication titled " Recapitulating endocrine cell clustering in culture promotes maturation of human stem cell-derived beta cells" in Nature Cell Biology.The whole protocol from hPSCs to eBCs takes 27 days.Reagents TrypLE Mouse embryonic broblasts \(MEFs) \(Gibco) PBS-/-\(Gibco) PBS+/+\(Gibco) Accumax \(Fisher #NC0443331) Rock inhibitor \(R&D #1254) Cell culture media MEF Media 100x MEM NEAA \(Life Tech #11140-050) FBS \(Thermo Sci #SH30071.03)1x DMEM \(Life Tech #11995-065) hESC Media 100x Glutamax \(Life Tech #35050-061) 100x MEM-NEAA \(Life Tech #11140-050) 100x Betamercaptoethanol \(Millipore #ES-007-E) KSR \(Life Tech #10828-028) DMEM/F-12 \(Life Tech #11320-033) FGF-2 -10ng/ml \(R&D 233-FB-025/C) Day 0 Media hESC media Activin A-10ng/ml \(R&D 338-AC/CF) HeregulinB -10 ng/ml \(Peprotech 100-03) Day 1 Media 100x Glutamax \(Life Tech #35050-061) 1x RPMI 1640 \(Mediatech #15-040-CM) FBS-0.2%\(Corning/Fisher -#35-011-CV) ITS-1:5,000 \(Gibco) Activin A-100 ng/ml \(338-AC/CF) Human WNT3a-50 ng/ml \(R&D -5036-WN-010/CF).Day 2 Media 100x Glutamax \(Life Tech #35050-061) 1x RPMI 1640 \(Mediatech #15-040-CM) FBS-0.2%\ (Corning/Fisher -#35-011-CV) ITS-1:2,000 \(Gibco) Activin A -100 ng/ml \(338-AC/CF) Day 3 Media 100x Glutamax \(Life Tech #35050-061) 1x RPMI 1640 \(Mediatech #15-040-CM) FBS-0.2%\(Corning/Fisher -#35-011-CV) ITS-1:1,000 \(Gibco) TGFbi IV-2.5 μM \(CalBioChem #616454) KGF-25 ng/ml \(R&D-251-KG-050/CF) Day 4-5 Media 100x Glutamax \(Life Tech #35050-061) 1x RPMI 1640 \(Mediatech #15-040-CM) FBS-0.4% \(Corning/Fisher -#35-011-CV) ITS -1:1,000 KGF-25 ng/ml \(R&D-#251-KG-050/CF) Day 6-7 Media 100x Glutamax \(Life Tech #35050-061) 1x DMEM \(Life Tech #11960-051) B27-1:100 \ (Gibco) TTNPB -3 nM \(Sigma-Aldrich#T3757) Day 8 Media 100x Glutamax \(Life Tech #35050-061) 1x DMEM \(Life Tech #11960-051) B27-1:100 \(Gibco) TTNPB -3 nM \(Sigma-Aldrich#T3757) EGF-50 ng/ml \(R&D #236-EG) Day 9-11 Media 100x Glutamax \(Life Tech #35050-061) 1x DMEM \(Life Tech #11960-051) B27-1:100 \(Gibco) EGF-50 ng/ml \(R&D #236-EG) KGF-50 ng/ml \(R&D-#251-KG-050/CF) Day 12-20 Media 100x Glutamax \(Life Tech #35050-061) 1x DMEM \(Life Tech #11960-051) B27-1:100 \(Gibco) NEAA-1:100 \(Gibco) ALKi II-10 μm \(Cayman Chemical #14794) LDN-193189 -500